Advertisement
Screener

Amgen Inc. (AMGN) Payments for (Proceeds from) Other Investing Activities

2.3 / 5 stars · 55/120 Roast Me

Amgen Inc. Payments for (Proceeds from) Other Investing Activities

Amgen Inc. (AMGN) reported Payments for (Proceeds from) Other Investing Activities of $60.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2026-08-05

  • Amgen Inc. payments for (proceeds from) other investing activities for the quarter ending 2026-06-30 was $56.00M, a 180.00% increase year-over-year.
  • Amgen Inc. payments for (proceeds from) other investing activities for the quarter ending 2026-03-31 was $4.00M, a 88.89% decline year-over-year.
  • Amgen Inc. payments for (proceeds from) other investing activities for the quarter ending 2025-12-31 was -$2.00M, a 106.45% decline year-over-year.
  • Amgen Inc. payments for (proceeds from) other investing activities for the quarter ending 2025-09-30 was -$22.00M.
  • Amgen Inc. payments for (proceeds from) other investing activities for fiscal 2025 was $32.00M.
  • Amgen Inc. payments for (proceeds from) other investing activities for fiscal 2024 was -$50.00M.
  • Amgen Inc. payments for (proceeds from) other investing activities for fiscal 2023 was -$224.00M.
  • Amgen Inc. payments for (proceeds from) other investing activities for fiscal 2022 was -$100.00M, a 152.08% decline from fiscal 2021.
Period endPayments for (Proceeds from) Other Investing Activities 3 monthPayments for (Proceeds from) Other Investing Activities 3 month as first filedPayments for (Proceeds from) Other Investing Activities 6 monthPayments for (Proceeds from) Other Investing Activities 6 month as first filedPayments for (Proceeds from) Other Investing Activities 9 monthPayments for (Proceeds from) Other Investing Activities 9 month as first filedPayments for (Proceeds from) Other Investing Activities 12 monthPayments for (Proceeds from) Other Investing Activities 12 month as first filed
2026-06-30$56.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$60.00M
10-Q · filed 2026-08-05
$58.00M
derived: sum of 3 quarters · filed 2026-08-05
$36.00M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$4.00M
10-Q · filed 2026-05-01
$2.00M
derived: sum of 2 quarters · filed 2026-05-01
-$20.00M
derived: sum of 3 quarters · filed 2026-05-01
$0.00
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
-$24.00M
derived: sum of 2 quarters · filed 2026-02-13
-$4.00M
derived: sum of 3 quarters · filed 2026-08-05
$32.00M
10-K · filed 2026-02-13
2025-09-30-$22.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$2.00M
derived: sum of 2 quarters · filed 2026-08-05
$34.00M
10-Q · filed 2025-11-05
$65.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$20.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$56.00M
10-Q · filed 2026-08-05
$87.00M
derived: sum of 3 quarters · filed 2026-08-05
$40.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$36.00M
10-Q · filed 2026-05-01
$67.00M
derived: sum of 2 quarters · filed 2026-05-01
$20.00M
derived: sum of 3 quarters · filed 2026-05-01
-$1.00M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31$31.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
-$16.00M
derived: sum of 2 quarters · filed 2026-02-13
-$37.00M
derived: sum of 3 quarters · filed 2026-02-13
-$50.00M
10-K · filed 2026-02-13
2024-09-30-$47.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$68.00M
derived: sum of 2 quarters · filed 2025-11-05
-$81.00M
10-Q · filed 2025-11-05
-$232.00M
derived: sum of 4 quarters · filed 2026-02-13
2024-06-30-$21.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
-$34.00M
10-Q · filed 2025-08-06
-$185.00M
derived: sum of 3 quarters · filed 2026-02-13
-$171.00M
derived: sum of 4 quarters · filed 2026-02-13
2024-03-31-$13.00M
10-Q · filed 2025-05-02
-$164.00M
derived: sum of 2 quarters · filed 2026-02-13
-$150.00M
derived: sum of 3 quarters · filed 2026-02-13
-$209.00M
derived: sum of 4 quarters · filed 2026-02-13
2023-12-31-$151.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
-$137.00M
derived: sum of 2 quarters · filed 2026-02-13
-$196.00M
derived: sum of 3 quarters · filed 2026-02-13
-$224.00M
10-K · filed 2026-02-13
-$225.00M
10-K · filed 2024-02-14
2023-09-30$14.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
-$45.00M
derived: sum of 2 quarters · filed 2024-10-31
-$73.00M
10-Q · filed 2024-10-31
-$74.00M
10-Q · filed 2023-10-31
-$232.00M
derived: sum of 4 quarters · filed 2025-02-14
2023-06-30-$59.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$87.00M
10-Q · filed 2024-08-07
-$246.00M
derived: sum of 3 quarters · filed 2025-02-14
-$126.00M
derived: sum of 4 quarters · filed 2025-02-14
2023-03-31-$28.00M
10-Q · filed 2024-05-03
-$187.00M
derived: sum of 2 quarters · filed 2025-02-14
-$67.00M
derived: sum of 3 quarters · filed 2025-02-14
-$81.00M
derived: sum of 4 quarters · filed 2025-02-14
2022-12-31-$159.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14
-$39.00M
derived: sum of 2 quarters · filed 2025-02-14
-$53.00M
derived: sum of 3 quarters · filed 2025-02-14
-$100.00M
10-K · filed 2025-02-14
$12.00M
10-K · filed 2023-02-09
2022-09-30$120.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31
$106.00M
derived: sum of 2 quarters · filed 2023-10-31
$59.00M
10-Q · filed 2023-10-31
$17.00M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-30-$14.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
-$61.00M
10-Q · filed 2023-08-04
-$103.00M
derived: sum of 3 quarters · filed 2024-02-14
$66.00M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-31-$47.00M
10-Q · filed 2023-04-28
-$89.00M
derived: sum of 2 quarters · filed 2024-02-14
$80.00M
derived: sum of 3 quarters · filed 2024-02-14
$66.00M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-31-$42.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$127.00M
derived: sum of 2 quarters · filed 2024-02-14
$113.00M
derived: sum of 3 quarters · filed 2024-02-14
$192.00M
10-K · filed 2024-02-14
$35.00M
10-K · filed 2022-02-16
2021-09-30$169.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04
$155.00M
derived: sum of 2 quarters · filed 2022-11-04
$234.00M
10-Q · filed 2022-11-04
$80.00M
10-Q · filed 2021-11-03
$275.00M
derived: sum of 4 quarters · filed 2023-02-09
2021-06-30-$14.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
$65.00M
10-Q · filed 2022-08-05
$62.00M
10-Q · filed 2021-08-04
$106.00M
derived: sum of 3 quarters · filed 2023-02-09
$92.00M
derived: sum of 4 quarters · filed 2023-02-09
2021-03-31$79.00M
10-Q · filed 2022-04-28
$120.00M
derived: sum of 2 quarters · filed 2023-02-09
$106.00M
derived: sum of 3 quarters · filed 2023-02-09
$153.00M
derived: sum of 4 quarters · filed 2023-02-09
2020-12-31$41.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09
$27.00M
derived: sum of 2 quarters · filed 2023-02-09
$74.00M
derived: sum of 3 quarters · filed 2023-02-09
$75.00M
10-K · filed 2023-02-09
2020-09-30-$14.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
$33.00M
derived: sum of 2 quarters · filed 2021-11-03
$34.00M
10-Q · filed 2021-11-03
-$220.00M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-30$47.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
$48.00M
10-Q · filed 2021-08-04
-$206.00M
derived: sum of 3 quarters · filed 2022-02-16
$64.00M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-31$1.00M
10-Q · filed 2021-04-28
-$253.00M
derived: sum of 2 quarters · filed 2022-02-16
$17.00M
derived: sum of 3 quarters · filed 2022-02-16
$23.00M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-31-$254.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
$16.00M
derived: sum of 2 quarters · filed 2022-02-16
$22.00M
derived: sum of 3 quarters · filed 2022-02-16
$28.00M
10-K · filed 2022-02-16
$52.00M
10-K · filed 2020-02-12
2019-09-30$270.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$276.00M
derived: sum of 2 quarters · filed 2020-10-29
$282.00M
10-Q · filed 2020-10-29
$119.00M
10-Q · filed 2019-10-30
$356.00M
derived: sum of 4 quarters · filed 2021-02-09
2019-06-30$6.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29
$12.00M
10-Q · filed 2020-07-29
$24.00M
10-Q · filed 2019-07-31
$86.00M
derived: sum of 3 quarters · filed 2021-02-09
$123.00M
derived: sum of 4 quarters · filed 2021-02-09
2019-03-31$6.00M
10-Q · filed 2020-05-01
$11.00M
10-Q · filed 2019-05-01
$80.00M
derived: sum of 2 quarters · filed 2021-02-09
$117.00M
derived: sum of 3 quarters · filed 2021-02-09
$113.00M
derived: sum of 4 quarters · filed 2021-02-09
2018-12-31$74.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09
$111.00M
derived: sum of 2 quarters · filed 2021-02-09
$107.00M
derived: sum of 3 quarters · filed 2021-02-09
$105.00M
10-K · filed 2021-02-09
$145.00M
10-K · filed 2019-02-13
2018-09-30$37.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30
$33.00M
derived: sum of 2 quarters · filed 2019-10-30
$31.00M
10-Q · filed 2019-10-30
$60.00M
derived: sum of 4 quarters · filed 2020-02-12
2018-06-30-$4.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
-$6.00M
10-Q · filed 2019-07-31
$23.00M
derived: sum of 3 quarters · filed 2020-02-12
$60.00M
derived: sum of 4 quarters · filed 2020-02-12
2018-03-31-$2.00M
10-Q · filed 2019-05-01
$27.00M
derived: sum of 2 quarters · filed 2020-02-12
$64.00M
derived: sum of 3 quarters · filed 2020-02-12
$94.00M
derived: sum of 4 quarters · filed 2020-02-12
2017-12-31$29.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12
$66.00M
derived: sum of 2 quarters · filed 2020-02-12
$96.00M
derived: sum of 3 quarters · filed 2020-02-12
$148.00M
10-K · filed 2020-02-12
$159.00M
10-K · filed 2018-02-13
2017-09-30$37.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31
$67.00M
derived: sum of 2 quarters · filed 2018-10-31
$119.00M
10-Q · filed 2018-10-31
$115.00M
derived: sum of 4 quarters · filed 2019-02-13
2017-06-30$30.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27
$82.00M
10-Q · filed 2018-07-27
$78.00M
derived: sum of 3 quarters · filed 2019-02-13
$288.00M
derived: sum of 4 quarters · filed 2019-02-13
2017-03-31$52.00M
10-Q · filed 2018-04-25
$48.00M
derived: sum of 2 quarters · filed 2019-02-13
$258.00M
derived: sum of 3 quarters · filed 2019-02-13
$300.00M
derived: sum of 4 quarters · filed 2019-02-13
2016-12-31-$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13
$206.00M
derived: sum of 2 quarters · filed 2019-02-13
$248.00M
derived: sum of 3 quarters · filed 2019-02-13
$243.00M
10-K · filed 2019-02-13
$222.00M
10-K · filed 2017-02-14
2016-09-30$210.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26
$252.00M
derived: sum of 2 quarters · filed 2017-10-26
$247.00M
10-Q · filed 2017-10-26
$262.00M
10-Q · filed 2016-10-28
$327.00M
derived: sum of 4 quarters · filed 2018-02-13
2016-06-30$42.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26
$37.00M
10-Q · filed 2017-07-26
$51.00M
10-Q · filed 2016-07-29
$117.00M
derived: sum of 3 quarters · filed 2018-02-13
$257.00M
derived: sum of 4 quarters · filed 2018-02-13
2016-03-31-$5.00M
10-Q · filed 2017-04-27
$75.00M
derived: sum of 2 quarters · filed 2018-02-13
$215.00M
derived: sum of 3 quarters · filed 2018-02-13
$339.00M
derived: sum of 4 quarters · filed 2018-02-13
2015-12-31$80.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
$220.00M
derived: sum of 2 quarters · filed 2018-02-13
$344.00M
derived: sum of 3 quarters · filed 2018-02-13
$447.00M
10-K · filed 2018-02-13
$392.00M
10-K · filed 2016-02-16
2015-09-30$140.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28
$264.00M
derived: sum of 2 quarters · filed 2016-10-28
$367.00M
10-Q · filed 2016-10-28
$312.00M
10-Q · filed 2015-11-02
$435.00M
derived: sum of 4 quarters · filed 2017-02-14
2015-06-30$124.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29
$227.00M
10-Q · filed 2016-07-29
$277.00M
10-Q · filed 2015-08-05
$295.00M
derived: sum of 3 quarters · filed 2017-02-14
$230.00M
derived: sum of 4 quarters · filed 2017-02-14
2015-03-31$103.00M
10-Q · filed 2016-05-02
$171.00M
derived: sum of 2 quarters · filed 2017-02-14
$106.00M
derived: sum of 3 quarters · filed 2017-02-14
$197.00M
derived: sum of 4 quarters · filed 2017-02-14
2014-12-31$68.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14
$3.00M
derived: sum of 2 quarters · filed 2017-02-14
$94.00M
derived: sum of 3 quarters · filed 2017-02-14
$138.00M
10-K · filed 2017-02-14
$135.00M
10-K · filed 2015-02-19
2014-09-30-$65.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02
$26.00M
derived: sum of 2 quarters · filed 2015-11-02
$70.00M
10-Q · filed 2015-11-02
$116.00M
derived: sum of 4 quarters · filed 2016-10-31
2014-06-30$91.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
$135.00M
10-Q · filed 2015-08-05
$181.00M
derived: sum of 3 quarters · filed 2016-10-31
$175.00M
derived: sum of 4 quarters · filed 2016-10-31
2014-03-31$44.00M
10-Q · filed 2015-04-27
$90.00M
derived: sum of 2 quarters · filed 2016-10-31
$84.00M
derived: sum of 3 quarters · filed 2016-10-31
$128.00M
derived: sum of 4 quarters · filed 2016-10-31
2013-12-31$46.00M
derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31
$40.00M
derived: sum of 2 quarters · filed 2016-10-31
$84.00M
derived: sum of 3 quarters · filed 2016-10-31
$90.00M
8-K · filed 2016-10-31
$70.00M
10-K · filed 2014-02-24
2013-09-30-$6.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29
$38.00M
derived: sum of 2 quarters · filed 2014-10-29
$44.00M
10-Q · filed 2014-10-29
$17.00M
derived: sum of 4 quarters · filed 2015-02-19
2013-06-30$44.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05
$50.00M
10-Q · filed 2014-08-05
$23.00M
derived: sum of 3 quarters · filed 2015-02-19
-$38.00M
derived: sum of 4 quarters · filed 2015-02-19
2013-03-31$6.00M
10-Q · filed 2014-04-30
-$21.00M
derived: sum of 2 quarters · filed 2015-02-19
-$82.00M
derived: sum of 3 quarters · filed 2015-02-19
$17.00M
derived: sum of 4 quarters · filed 2015-02-19
2012-12-31-$27.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19
-$88.00M
derived: sum of 2 quarters · filed 2015-02-19
$11.00M
derived: sum of 3 quarters · filed 2015-02-19
$11.00M
10-K · filed 2015-02-19
$36.00M
10-K · filed 2013-02-27
2012-09-30-$61.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29
$38.00M
derived: sum of 2 quarters · filed 2013-10-29
$38.00M
10-Q · filed 2013-10-29
$4.00M
derived: sum of 4 quarters · filed 2014-02-24
2012-06-30$99.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
$99.00M
10-Q · filed 2013-08-06
$65.00M
derived: sum of 3 quarters · filed 2014-02-24
$49.00M
derived: sum of 4 quarters · filed 2014-02-24
2012-03-31$0.00
10-Q · filed 2013-05-03
-$34.00M
derived: sum of 2 quarters · filed 2014-02-24
-$50.00M
derived: sum of 3 quarters · filed 2014-02-24
-$51.00M
derived: sum of 4 quarters · filed 2014-02-24
2011-12-31-$34.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24
-$50.00M
derived: sum of 2 quarters · filed 2014-02-24
-$51.00M
derived: sum of 3 quarters · filed 2014-02-24
-$45.00M
10-K · filed 2014-02-24
2011-09-30-$16.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06
-$17.00M
derived: sum of 2 quarters · filed 2012-11-06
-$11.00M
10-Q · filed 2012-11-06
$12.00M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-30-$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08
$5.00M
10-Q · filed 2012-08-08
$28.00M
derived: sum of 3 quarters · filed 2013-02-27
$54.00M
derived: sum of 4 quarters · filed 2013-02-27
2011-03-31$6.00M
10-Q · filed 2012-05-08
$29.00M
derived: sum of 2 quarters · filed 2013-02-27
$55.00M
derived: sum of 3 quarters · filed 2013-02-27
$91.00M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-31$23.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
$49.00M
derived: sum of 2 quarters · filed 2013-02-27
$85.00M
derived: sum of 3 quarters · filed 2013-02-27
$97.00M
10-K · filed 2013-02-27
2010-09-30$26.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
$62.00M
derived: sum of 2 quarters · filed 2011-11-04
$74.00M
10-Q · filed 2011-11-04
$69.00M
derived: sum of 4 quarters · filed 2012-02-29
2010-06-30$36.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08
$48.00M
10-Q · filed 2011-08-08
$43.00M
derived: sum of 3 quarters · filed 2012-02-29
-$35.00M
derived: sum of 4 quarters · filed 2012-02-29
2010-03-31$12.00M
10-Q · filed 2011-05-10
$7.00M
derived: sum of 2 quarters · filed 2012-02-29
-$71.00M
derived: sum of 3 quarters · filed 2012-02-29
-$54.00M
derived: sum of 4 quarters · filed 2012-02-29
2009-12-31-$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29
-$83.00M
derived: sum of 2 quarters · filed 2012-02-29
-$66.00M
derived: sum of 3 quarters · filed 2012-02-29
-$51.00M
10-K · filed 2012-02-29
2009-09-30-$78.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08
-$61.00M
derived: sum of 2 quarters · filed 2010-11-08
-$46.00M
10-Q · filed 2010-11-08
-$81.00M
derived: sum of 4 quarters · filed 2011-02-25
2009-06-30$17.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09
$32.00M
10-Q · filed 2010-08-09
-$3.00M
derived: sum of 3 quarters · filed 2011-02-25
-$35.00M
derived: sum of 4 quarters · filed 2011-02-25
2009-03-31$15.00M
10-Q · filed 2010-05-07
-$20.00M
derived: sum of 2 quarters · filed 2011-02-25
-$52.00M
derived: sum of 3 quarters · filed 2011-02-25
2008-12-31-$35.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25
-$67.00M
derived: sum of 2 quarters · filed 2011-02-25
-$128.00M
10-K · filed 2011-02-25
2008-09-30-$32.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-06
-$93.00M
10-Q · filed 2009-11-06
2008-06-30-$61.00M
10-Q · filed 2009-08-10
2007-12-31-$24.00M
10-K · filed 2010-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
GILEAD SCIENCES, INC. (GILD)United States$185.522B-48.37
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31